Insulin Pump Therapy (Continuous Subcutaneous Insulin Infusion)

Primary Care - Clinics in Office Practice

Volumn 34, Issue 4, 2007, Pages 845-871

  White, Russell D ^a  

^a TRUMAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN LISPRO;

CONTINUOUS INFUSION; DIABETIC PATIENT; DRUG DELIVERY SYSTEM; ECONOMICS; EXERCISE; FAMILY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; MENSTRUATION; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDIATRICS; PHYSIOLOGY; PREGNANCY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STOMACH PARESIS; TREATMENT INDICATION; WORK; WORK SCHEDULE;

ADMINISTRATION, CUTANEOUS; DIABETES MELLITUS; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; QUALITY OF LIFE;

EID: 36549050305     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2007.07.005     Document Type: Review

References (56)

1. Pickup J.C., Keen H., Parsons J.A., et al. The use of continuous subcutaneous insulin infusion to achieve normoglycaemia in diabetic patients. [abstract]. Diabetologia 13 (1977) 425A
2. Pickup J.C., Keen H., Stevenson R.W., et al. Insulin via continuous subcutaneous infusion. Lancet 2 8097 (1978) 988-989
3. Pickup J.C., Keen H., Parson J.C., et al. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J 1 (1978) 204-207
4. Pickup J.C., Keen H., Viberti G.C., et al. Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 3 2 (1980) 290-300
5. Millennium Research Group. US markets for drug delivery 2005 (2004), Millennium Research Group, Toronto (Canada)
6. CDC. National diabetes fact sheet 2005. Available at: http://www.cdc.gov/diabetes/pubs/estimates05.htm. Accessed January 2006.
7. Lenhard M.J., and Reeves D. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 161 19 (2001) 2293-2300
8. Marcus A.O. The art and science of insulin-pump therapy. In: Leahy J.L., and Cefalu W.T. (Eds). Insulin therapy (2002), Marcel Dekker, Inc., New York 223-244
9. Pickup J., and Keen H. Continuous subcutaneous insulin infusion at 25 years. Diabetes Care 25 (2002) 593-598
10. Skylar J.S., Hirsch I.B., Clark N.G., et al. Insulin therapy in the 21st century (2003), American Diabetes Association, Alexandria (VA)
11. Mayfield J.A., and White R.D. Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function. Am Fam Physician 70 11 (2004) 489-500
12. Zinman B., Tildesley H., Chiasson J.-L., et al. Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 46 (1997) 440-443
13. Lougheed W.D., Zinman B., Strack T.R., et al. Stability of insulin lispro in insulin infusion systems. Diabetes Care 20 7 (1997) 1061-1065
14. Bode B.W., Sabbah H.T., Groww T.M., et al. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 18 Suppl 1 (2002) S14-S20
15. Cryer P.E., Fisher J.N., and Shamoon H. Hypoglycemia. Diabetes Care 17 7 (1994) 734-755
16. Bode B.W., Steed R.D., and Davidson P.C. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19 4 (1996) 324-327
17. Jeha G.S., Karaviti L.P., Anderson B., et al. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hyopoglycemia. Diabetes Technol Ther 7 (2005) 876-884
18. Cryer P.E., Davis P.E., and Shamoon H. Hypoglycemia in diabetes. Diabetes Care 26 6 (2003) 1902-1912
19. Walsh J., and Roberts R. Pumping insulin. 3rd edition (2000), Torrey Pines Press, San Diego (CA) ISBN 1-884804-84-5
20. White R.D. The runner with diabetes. In: O'Connor F.G., and Wilder R.P. (Eds). The textbook of running medicine (2001), McGraw-Hill Company, New York 371-385
21. Bolli G.B., Perriello G., Fanelli C.G., et al. Nocturnal blood glucose control in type I diabetes mellitus. Diabetes Care 16 Suppl 3 (1993) 71-89
22. Bolli G.B., and Gerich J.E. The "dawn phenomenon"-a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med 310 12 (1984) 746-750
23. Perriello G., De Feo P., Torlone E., et al. The dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variablility, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia 34 (1991) 21-28
24. Schmidt M.I., Hadji-Georgopoulos A., Rendell M., et al. Fasting hyperglycemia and associated free insulin and cortisol changes in "Somogyi-like" patients. Diabetes Care 2 (1979) 457-464
25. Geffner M.E., Frank H.J., Kaplan S.A., et al. Early morning hyperglycemia in diabetic individuals treated with continuous subcutaneous insulin infusion. Diabetes Care 6 2 (1983) 135-139
26. Schmidt M.I., Hadji-Georgopoulos A., Rendell M., et al. The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care 4 6 (1981) 579-585
27. Gabbe S.G., Holding E., Temple P., et al. Benefits, risks, costs and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 182 (2000) 1283-1291
28. Simmons D., Thompson C.F., and Conroy. C, et al. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 24 12 (2001) 2078-2082
29. Steindel B.S., Roe T.R., Costin G., et al. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 27 3 (1995) 199-204
30. In: Wolpert H.A. (Ed). Smart pumping: a practical approach to mastering the insulin pump (2002), American Diabetes Association, Alexandria (VA)
31. Weiland D.A., and White R.D. Diabetes mellitus. Clin Fam Pract (2002) 703-752
32. Rudolph J., and Hirsch I.B. Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic. Endocr Pract 8 (2002) 401-405 2003:2254-64
33. Rizvi A.A., Petry R., Arnold M.B., et al. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes. Endocr Pract 7 (2001) 364-369
34. Unger J. Intensive management of type 1 diabetes. Emerg Med 33 (2001) 30-42
35. Raskin P., Bode B.W.Q., Marks J.B., et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes. Diabetes Care 26 9 (2003) 2598-2603
36. Holman R.R. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Res Clin Pract 40 Suppl (1998) S21-S25
37. DeWitt D.E., and Hirsch I.B. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus. JAMA 289 17 (2003) 2254-2264
38. Mudaliar S., and Edelman S.V. Insulin therapy in type 2 diabetes. Endocrinol Metab Clin North Am 30 (2001) 936-982
39. Department of Health & Human Services (DHHS) Centers for Medicare & Medicaid Services. Medicare coverage issues manual. HCFA. Available at: http://cms.hbs.gov/transmittals/downloadsR143CIM.pdf. Accessed September 2007.
40. American Diabetes Association. Continuous subcutaneous insulin infusion. Diabetes Care 25 Suppl 1 (2002) S116
41. Duckworth W.C., Saudek C.D., Giobbie-Hurdere A., et al. The Veterans Affairs implantable insulin pump study. Diabetes Care 21 10 (1998) 1596-1602
42. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 14 (1993) 977-986
43. American Diabetes Association. Medical management of type 1 diabetes. 4th edition (2003), American Diabetes Association, Alexandria (VA)
44. Jovanovic-Peterson L., Peterson C.M., Reed G.F., et al. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development-Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 164 (1991) 103-111
45. Fanelli C., Pampanelli S., Epifano L., et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37 (1994) 1265-1276
46. Clement S., Braithwaite S.S., Ahman A., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27 2 (2004) 553-591
47. Lauritzen T., Pramming S., Deckert T., et al. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 24 (1983) 326-329
48. Mudaliar S., Lindberg F.A., Joyce M., et al. Insulin aspart (B28 Asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular insulin in healthy nondiabetic subjects. Diabetes Care 22 9 (1999) 1501-1506
49. Hirsch I.B. Insulin analogues. N Engl J Med 352 2 (2005) 174-183
50. Chantelau E., Spraul M., Muhlhauser I., et al. Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 32 (1989) 421-426
51. Boland E.A., Grey M., Oesterle A., et al. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in -adolescents with type 1 diabetes. Diabetes Care 22 11 (1999) 1779-1784
52. Maniatis A.K., Klingensmith G.J., Slover R.H., et al. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 107 (2001) 351-356
53. Weissberg-Benchell J., Antisdel-Lomaglio J., and Sehadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 26 4 (2003) 1079-1087
54. Turrentine L.A., Wallander J.L., Roth D.L., et al. The influence on quality of life of continuous subcutaneous insulin infusion (CSII) therapy. Diabetes 50 Suppl1 (2001) A49
55. Graff M.R., Rubin R.R., and Walker E.A. How diabetes specialists treat their own diabetes: findings form a study of the AADE and ADA membership. Diabetes 50 Suppl1 (2001) A49
56. Kanakis S.J., Watts C., and Leichter S.B. The business of insulin pumps in diabetes care: clinical and economic considerations. Clinical Diabetes 20 (2002) 214-216